We further classified these patients into four different groups (CAFshigh T:S ratiohigh, CAFshigh T:S ratiolow, CAFslow T:S ratiohigh, and CAFslow T:S ratiolow) according to CAFs density and CD8+ T cells T:S ratio in cervical cancer. This evidence concerns the gene CD8A and cervical carcinoma.